updates on ropeginterferon in pv
Published 3 years ago • 738 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
1:41
updates on ropeginterferon in mpns
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
2:06
clinical updates on the use of ropeginterferon for polycythemia vera
-
1:39
upcoming agents in et and pv
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
2:05
ropeg in polycythemia vera: long-term proud-pv and conti-pv results
-
1:00:29
penyakit autoimun darah dengan penurunan trombosit dan bercak merah di kuli itp
-
15:06
ropeginterferon, welcome to the us
-
6:24
polycythemia vera: latest updates for patients & caregivers in 2022 | dr. ruben mesa | blood cancer
-
3:29
current approaches and new approvals in mf and pv
-
2:40
safety and efficacy of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
3:00
ropeginterferon alpha-2b as an effective treatment against pv
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
0:56
rop-et: a phase iii non-randomized study of ropeginterferon alfa-2b in patients with et
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:02
conti-pv: a 2-year follow-up of interferon product aop2014